Skip to main content
×
×
Home

Do not blame the SSRIs: blame the Hamilton Depression Rating Scale

  • Søren Dinesen Østergaard (a1)
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Do not blame the SSRIs: blame the Hamilton Depression Rating Scale
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Do not blame the SSRIs: blame the Hamilton Depression Rating Scale
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Do not blame the SSRIs: blame the Hamilton Depression Rating Scale
      Available formats
      ×
Abstract
Copyright
Corresponding author
E-mail: soeoes@rm.dk
References
Hide All
1. Jakobsen, JC, Katakam, KK, Schou, A et al. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry 2017;17:58.
2. Videnskab.dk. 9 February 2017. Available at http://videnskab.dk/krop-sundhed/nyt-studie-lykkepiller-har-ingen-effekt-paa-depression (in Danish).
3. Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:5662.
4. Hamilton, M. The Hamilton Depression Scales. In: Sartorius N, Ban TA, editors. Assessment of Depression. Berlin, Germany: Springer, 1986.
5. Bech, P. Clinical Psychometrics. Oxford, UK: Wiley-Blackwell, 2012.
6. Bech, P, Gram, LF, Dein, E, Jacobsen, O, Vitger, J, Bolwig, TG. Quantitative rating of depressive states. Acta Psychiatr Scand 1975;51:161170.
7. Bech, P, Allerup, P, Gram, LF et al. The Hamilton Depression Scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand 1981;63:290299.
8. Ostergaard, SD, Bech, P, Trivedi, MH, Wisniewski, SR, Rush, AJ, Fava, M. Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the Research Domain Criteria (RDoC). J Affect Disord 2014;163:1824.
9. Ostergaard, SD, Meyers, BS, Flint, AJ et al. Measuring psychotic depression. Acta Psychiatr Scand 2014;129:211220.
10. Ostergaard, SD, Bech, P, Miskowiak, KW. Fewer study participants needed to demonstrate superior antidepressant efficacy when using the Hamilton Melancholia Subscale (HAM-D(6)) as outcome measure. J Affect Disord 2016;190:842845.
11. Licht, RW, Qvitzau, S, Allerup, P, Bech, P. Validation of the Bech-Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression; is the total score a valid measure of illness severity? Acta Psychiatr Scand 2005;111:144149.
12. Bech, P, Fava, M, Trivedi, MH, Wisniewski, SR, Rush, AJ. Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets. J Affect Disord 2011;132:396400.
13. Martiny, K, Refsgaard, E, Lund, V et al. The day-to-day acute effect of wake therapy in patients with major depression using the HAM-D6 as primary outcome measure: results from a randomised controlled trial. PLoS One 2013;8:e67264.
14. Kyle, PR, Lemming, OM, Timmerby, N, Sondergaard, S, Andreasson, K, Bech, P. The validity of the different versions of the Hamilton Depression Scale in separating remission rates of placebo and antidepressants in clinical trials of major depression. J Clin Psychopharmacol 2016;36:453456.
15. Korner, A, Lauritzen, L, Abelskov, K et al. Rating scales for depression in the elderly: external and internal validity. J Clin Psychiatry 2007;68:384389.
16. Bagby, RM, Ryder, AG, Schuller, DR, Marshall, MB. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 2004;161:21632177.
17. Bech, P, Cialdella, P, Haugh, MC et al. Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression. Br J Psychiatry 2000;176:421428.
18. Hieronymus, F, Emilsson, JF, Nilsson, S, Eriksson, E. Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Mol Psychiatry 2016;21:523530.
19. Bech, P, Kajdasz, DK, Porsdal, V. Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder. Psychopharmacology (Berl) 2006;188:273280.
20. Bech, P, Boyer, P, Germain, JM et al. HAM-D17 and HAM-D6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major depressive disorder. Pharmacopsychiatry 2010;43:271276.
21. Bech, P. Applied psychometrics in clinical psychiatry: the pharmacopsychometric triangle. Acta Psychiatr Scand 2009;120:400409.
22. Bech, P, Fava, M, Trivedi, MH, Wisniewski, SR, Rush, AJ. Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial. Acta Psychiatr Scand 2012;125:342348.
23. Bech, P, Gefke, M, Lunde, M, Lauritzen, L, Martiny, K. The pharmacopsychometric triangle to illustrate the effectiveness of T-PEMF concomitant with antidepressants in treatment resistant patients: a double-blind, randomised, sham-controlled trial revisited with focus on the patient-reported outcomes. Depress Res Treat 2011;2011:806298.
24. Papakostas, GI, Ostergaard, SD, Iovieno, N. The nature of placebo response in clinical studies of major depressive disorder. J Clin Psychiatry 2015;76:456466.
25. Montgomery, SA, Asberg, M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382389.
26. Beck, AT, Ward, CH, Mendelson, M, Mock, J, Erbaugh, J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561571.
27. Bech, P, Allerup, P, Larsen, ER, Csillag, C, Licht, RW. The Hamilton Depression Scale (HAM-D) and the Montgomery-Asberg Depression Scale (MADRS). A psychometric re-analysis of the European genome-based therapeutic drugs for depression study using Rasch analysis. Psychiatry Res 2014;217:226232.
28. Bouman, TK, Kok, AR . Homogeneity of Beck’s Depression Inventory (BDI): applying Rasch analysis in conceptual exploration. Acta Psychiatr Scand 1987;76:568573.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Acta Neuropsychiatrica
  • ISSN: 0924-2708
  • EISSN: 1601-5215
  • URL: /core/journals/acta-neuropsychiatrica
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed